Next, we intratumorally injected cholesterol-conjugated siRNAs targeting ZCCHC4 and also intraperitoneally injected OXA into HCC-bearing mice following the schedule shown in Fig. 3d. The gene discussed is ZCCHC4; the disease is hepatocellular carcinoma.